Population pharmacokinetics and bioavailability of tacrolimus oral suspension in children with haematopoietic stem cell transplant

Documenti analoghi

• Excellent outcomes in children after haematopoietic stem cell transplantation for hepatitis‐associated aplastic anaemia following liver transplantation
  di: Satish Kumar Meena, et al.
  Pubblicazione: (2026)
• Effects of routes, concentrations and genetic polymorphisms on posaconazole–tacrolimus interactions in allogeneic haematopoietic cell transplantation
  di: Masatomo Kuno, et al.
  Pubblicazione: (2025)
• Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney‐transplanted patients
  di: Katrine Agergaard, et al.
  Pubblicazione: (2024)
• Utility of transplant conditioning intensity score in allogeneic haematopoietic stem cell transplantation for genetic disorders
  di: Koji Kawaguchi, et al.
  Pubblicazione: (2026)
• Avatrombopag for post‐transplant thrombocytopenia following allogeneic haematopoietic stem cell transplantation: A single‐centre retrospective study
  di: Cristian Alberdi‐Lema, et al.
  Pubblicazione: (2026)